Jason Clark
Chief Scientific Officer NexaBiome
Seminars
Thursday 26th March 2026
Panel Discussion: Building a Unified Global Framework to Enable Scalable Phage Development, Investment Confidence & Market Access
9:30 am
- Comparing evolving regulatory approaches across regions to identify opportunities for alignment that de-risk development for investors
- Evaluating how harmonised guidance could accelerate approval timelines, reduce duplicated effort and strengthen the commercial case for phage therapies
- Exploring how global partnerships, data-sharing initiatives and transparent evidence standards can unlock greater investment, set new regulatory precedents and enable scalable, sustainable phage innovation
Thursday 26th March 2026
Establishing a Clear & Predictable UK Regulatory Pathway to Accelerate Clinical Phage Access
9:00 am
- Examining how MHRA, NICE and NHS England are shaping a national framework for phage therapy evaluation
- Understanding opportunities created by the Innovative Medicines Fund and adaptive licensing pilots
- Outlining the next steps needed to transition from compassionate-use approvals to standardised national access
